'Extra Time' podcast. In conversation with Professor Chris Molloy
04 Oct 2020
Professor Chris Molloy & Dr Adam M Hill
Adam talks to Professor Chris Molloy, CEO of the UK's Medicines Discovery Catapult, the National Research Technology Facility supporting the sector by industrialising and driving the adoption of new approaches to discovering medicines.
Most recently, Chris has been responsible for establishing and running the Lighthouse Labs, the biggest diagnostic lab in British history. Developed in partnership with AstraZeneca and GSK, these labs provide diagnostics infrastructure, which have the capability to test tens of thousands of patient samples each day for Coronavirus.
Chris talks about the herculean task he and his team had in setting up the LightHouse Labs, what he is most proud of and with the lab infrastructure now in place, what are the opportunities to test, trace, and better stratify patients into various forms of therapies in the United Kingdom.
We are delighted to be working with [Oncimmune] and the IMPACTT program is built upon the fact that the answer to most of the questions that we have in medicine's discovery and diagnostics lies in the patient.
Professor Chris Molloy